Success Metrics

Clinical Success Rate
97.0%

Based on 32 completed trials

Completion Rate
97%(32/33)
Active Trials
0(0%)
Results Posted
9%(3 trials)
Terminated
1(3%)

Phase Distribution

Ph phase_2
3
8%
Ph not_applicable
1
3%
Ph phase_4
8
22%
Ph phase_3
8
22%
Ph phase_1
15
41%

Phase Distribution

15

Early Stage

3

Mid Stage

16

Late Stage

Phase Distribution35 total trials
Phase 1Safety & dosage
15(42.9%)
Phase 2Efficacy & side effects
3(8.6%)
Phase 3Large-scale testing
8(22.9%)
Phase 4Post-market surveillance
8(22.9%)
N/ANon-phased studies
1(2.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

97.0%

32 of 33 finished

Non-Completion Rate

3.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

37

all time

Status Distribution
Completed(32)
Terminated(1)
Other(4)

Detailed Status

Completed32
unknown4
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
37
Active
0
Success Rate
97.0%
Most Advanced
Phase 4

Trials by Phase

Phase 115 (42.9%)
Phase 23 (8.6%)
Phase 38 (22.9%)
Phase 48 (22.9%)
N/A1 (2.9%)

Trials by Status

completed3286%
terminated13%
unknown411%

Recent Activity

Clinical Trials (37)

Showing 20 of 37 trialsScroll for more
NCT05930028Phase 3

A Study to Evaluate the Efficacy and Safety of BR1017A and BR1017B Combination Therapy in Essential Hypertension Patients With Primary Hypercholesterolemia

Completed
NCT05173025Phase 4

Effect of Fimasartan on Extended RAS and Vascular Functions in Patients With Type 2 Diabetes and Hypertension

Unknown
NCT02022774

Efficacy of fimaSartan on arTerIal stiFFness iN patiEntS With HypertenSion

Completed
NCT02248961Phase 3

Efficacy and Safety Evaluating Study to Compare Kanarb (Fimasartan) and Cozaar® (Losartan) in Adult Patients With Grade I-II Arterial Hypertension

Completed
NCT02704702Phase 1

A Clinical Trial to Evaluate the Pharmacokinetics and Safety of Fimasartan and Rosuvastatin in Healthy Male Subjects

Completed
NCT01384747Phase 4

Effect of Fimasartan for Modification of Atheroma Vulnerability in DEFERred Coronary Disease (FIMA-DEFER)

Terminated
NCT00922480Phase 3

Clinical Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan in Hypertension Patients

Completed
NCT03219632

Fimasartan on Hypertensive Cardiac Disease With Left Ventricular Hypertrophy Estimated by ECG

Completed
NCT02495324Phase 4

Fimasartan Achieving SBP Target (FAST) Study

Completed
NCT02312375Not Applicable

Effects of Fimasartan on Insulin Secretion in Type 2 Diabetic Patients

Completed
NCT02166814Phase 3

A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Combination of Fimasartan/Rosuvastatin in Comparison to Each Component Administered Alone in Patients With Essential Hypertension and Dyslipidemia

Completed
NCT02958631Phase 4

Comparison of Blood Pressure Lowering Effect Between Fimasartan and Losartan

Unknown
NCT01736488Phase 4

Clinical Study to Evaluate the Antihypertensive Efficacy and Changes of Neurohormonal Markers of Fimasartan and Atenolol With Exaggerated Blood Pressure Response During Exercise in Essential Hypertensive Patients

Completed
NCT01671020Phase 1

Clinical Trials for Single Oral Dose of 60mg Fimasartan and Single IV Infusion of 30mg Fimasartan to Evaluate the Absolute Bioavailability of Kanarb® Tablet (Fimasartan) in Healthy Subjects

Completed
NCT02222480Phase 2

A Clinical Trial to Evaluate Efficacy, Tolerability, and Pharmacokinetic-Pharmacodynamic Relationship of Fimasartan/Hydrochlorothiazide

Completed
NCT01672476Phase 3

A Multicenter, Phase 3 Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan(BR-A-657∙K) 30mg Compared to Placebo in Patients With Mild to Moderate Essential Hypertension

Completed
NCT02566187Phase 1

A Study to Compare the Pharmacokinetics of Fimasartan/Atorvastatin Combination Tablet

Completed
NCT01691118Phase 4

A Trial of Fimasartan for Early Diastolic Heart Failure

Completed
NCT02152306Phase 3

Fimasartan/Amlodipine Combination Phase III

Completed
NCT02397538Phase 1

Study to Evaluate the Pharmacokinetic Interaction and Safety After Multiple Oral Doses of Fimasartan/Amlodipine and Rosuvastatin in Healthy Male Subjects

Completed

Drug Details

Intervention Type
DRUG
Total Trials
37